CXCL1 and neoplasm: Notably, there is loss of CXCL1, IL6 and IL8 expression in the CSF for Patients C and D when there was disease progression. Of interest, the cytokine, angiogenin has a significantly higher expression in Patient E (non MYC-amplified) when there is tumour recurrence.